Manuel Llobet

Manuel Llobet

Chief Executive Officer presso ALLERGY THERAPEUTICS PLC

Patrimonio netto: 189 545 $ in data 31/03/2024

60 anni
Health Technology
Consumer Services
Distribution Services

Profilo

Manuel Llobet is currently the Chief Executive Officer and Executive Director at Allergy Therapeutics Plc, where he has been working since 2009.
He is also a Director at Allergy Therapeutics (UK) Ltd.
and Allergy Therapeutics (Holdings) Ltd.
Additionally, he is the Managing Director at Bencard Allergie GmbH.
Previously, he worked as the Chief Executive Officer at Laboratorios Andrómaco SA, Executive Director at Corporación Drokasa SA, and Manager of Business Development at Laboratorio Chile SA. Mr. Llobet received his undergraduate degree from Ramon Llull University and his MBA from Instituto de Estudios Superiores de la Empresa.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
16/11/2023 5 001 200 ( 0.10% ) 189 545 $ 31/03/2024

Posizioni attive di Manuel Llobet

SocietàPosizioneInizio
ALLERGY THERAPEUTICS PLC Chief Executive Officer 01/09/2009
Director/Board Member -
Chief Executive Officer -
Director/Board Member 01/10/2009
Tutte le posizioni attive di Manuel Llobet

Precedenti posizioni note di Manuel Llobet

SocietàPosizioneFine
Corporate Officer/Principal -
LABORATORIOS ANDROMACO S.A. President -
Director/Board Member -
Vedi nel dettaglio l'esperienza di Manuel Llobet

Formazione di Manuel Llobet

Ramon Llull University Undergraduate Degree
Instituto de Estudios Superiores de la Empresa Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Manuel Llobet

Relazioni

29

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
ALLERGY THERAPEUTICS PLC

Health Technology

Aziende private6

Health Technology

Health Technology

Distribution Services

Health Technology

Finance

Health Technology

Vedi le connessioni aziendali